An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network study (CERN).
DeWire M, Fouladi M, Turner DC, Wetmore C, Hawkins C, Jacobs C, Yuan Y, Liu D, Goldman S, Fisher P, Rytting M, Bouffet E, Khakoo Y, Hwang EI, Foreman N, Stewart CF, Gilbert MR, Gilbertson R, Gajjar A.
DeWire M, et al. Among authors: khakoo y.
J Neurooncol. 2015 May;123(1):85-91. doi: 10.1007/s11060-015-1764-7. Epub 2015 Apr 10.
J Neurooncol. 2015.
PMID: 25859842
Free PMC article.
Clinical Trial.